SPMIP5
gene geneOn this page
Also known as MGC33547Em:AC016825.4
Summary
SPMIP5 (sperm microtubule inner protein 5, HGNC:28500) is a protein-coding gene on chromosome 10q25.3, encoding Sperm-associated microtubule inner protein 5 (Q8WW14). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in flagellum axoneme.
Predicted to be involved in flagellated sperm motility. Predicted to be located in several cellular components, including cytoskeleton; motile cilium; and nucleus. Predicted to be active in axonemal A tubule inner sheath and sperm flagellum.
Source: NCBI Gene 143379 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001350931
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28500 |
| Approved symbol | SPMIP5 |
| Name | sperm microtubule inner protein 5 |
| Location | 10q25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33547, Em:AC016825.4 |
| Ensembl gene | ENSG00000165863 |
| Ensembl biotype | protein_coding |
| Entrez | 143379 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 7 protein_coding, 2 retained_intron
ENST00000369210, ENST00000467153, ENST00000588184, ENST00000588224, ENST00000865230, ENST00000865231, ENST00000936567, ENST00000936568, ENST00000936569
RefSeq mRNA: 4 — MANE Select: NM_001350931
NM_001330142, NM_001350930, NM_001350931, NM_144661
CCDS: CCDS7596, CCDS81510
Canonical transcript exons
ENST00000588184 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001193252 | 116664761 | 116664947 |
| ENSE00001224087 | 116665608 | 116665826 |
| ENSE00002898275 | 116669927 | 116669966 |
| ENSE00002946554 | 116663696 | 116664051 |
| ENSE00003469188 | 116664174 | 116664271 |
| ENSE00003525384 | 116668258 | 116668323 |
Expression profiles
Bgee: expression breadth ubiquitous, 153 present calls, max score 97.92.
FANTOM5 (CAGE): breadth broad, TPM avg 1.9490 / max 96.5322, expressed in 444 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 111559 | 1.7798 | 438 |
| 111555 | 0.0754 | 3 |
| 111558 | 0.0727 | 41 |
| 111557 | 0.0143 | 3 |
| 111556 | 0.0069 | 3 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.92 | gold quality |
| left testis | UBERON:0004533 | 95.62 | gold quality |
| right testis | UBERON:0004534 | 95.02 | gold quality |
| secondary oocyte | CL:0000655 | 94.61 | gold quality |
| testis | UBERON:0000473 | 93.80 | gold quality |
| adult organism | UBERON:0007023 | 93.53 | gold quality |
| oocyte | CL:0000023 | 93.23 | gold quality |
| adrenal tissue | UBERON:0018303 | 89.12 | gold quality |
| tibial nerve | UBERON:0001323 | 84.57 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.78 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 77.57 | gold quality |
| cortical plate | UBERON:0005343 | 75.96 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 75.28 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 75.21 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 74.03 | gold quality |
| hypothalamus | UBERON:0001898 | 73.63 | gold quality |
| left ovary | UBERON:0002119 | 71.24 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.24 | gold quality |
| ovary | UBERON:0000992 | 69.74 | gold quality |
| superficial temporal artery | UBERON:0001614 | 69.63 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 69.31 | gold quality |
| adrenal gland | UBERON:0002369 | 68.42 | gold quality |
| right adrenal gland | UBERON:0001233 | 68.25 | gold quality |
| thyroid gland | UBERON:0002046 | 68.16 | gold quality |
| left adrenal gland | UBERON:0001234 | 67.65 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 67.58 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 67.42 | gold quality |
| lower esophagus | UBERON:0013473 | 67.36 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.22 | gold quality |
| right ovary | UBERON:0002118 | 67.21 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.42 |
| E-MTAB-6379 | no | 2.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting SPMIP5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-3156-3P | 99.76 | 66.72 | 939 |
| HSA-MIR-513A-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-513C-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-324-3P | 99.26 | 66.31 | 1034 |
| HSA-MIR-4758-3P | 99.12 | 63.96 | 869 |
| HSA-MIR-1178-3P | 98.57 | 67.09 | 890 |
| HSA-MIR-4691-3P | 98.11 | 66.83 | 1204 |
| HSA-MIR-4736 | 97.96 | 65.89 | 1287 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-1306-5P | 97.11 | 64.04 | 755 |
| HSA-MIR-6729-3P | 96.91 | 66.79 | 703 |
| HSA-MIR-6820-5P | 94.04 | 61.13 | 161 |
| HSA-MIR-553 | 94.01 | 65.93 | 158 |
| HSA-MIR-658 | 88.20 | 67.03 | 178 |
| HSA-MIR-1268A | 87.06 | 61.46 | 145 |
| HSA-MIR-1268B | 87.06 | 61.46 | 145 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spmip5 | ENSMUSG00000026931 |
| rattus_norvegicus | Spmip5 | ENSRNOG00000025953 |
Protein
Protein identifiers
Sperm-associated microtubule inner protein 5 — Q8WW14 (reviewed: Q8WW14)
All UniProt accessions (1): Q8WW14
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in flagellum axoneme. May serve to reinforce and thus stabilize the microtubule structure in the sperm flagella.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules.
Subcellular location. Cytoplasm. Cytoskeleton. Flagellum axoneme. Nucleus.
Tissue specificity. Expressed in testis (at protein level). Strongly expressed in peritubular cells and Leydig cells and weakly expressed in the cytoplasm of spermatocytes.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WW14-1 | 1 | yes |
| Q8WW14-2 | 2 | |
| Q8WW14-3 | 3 |
RefSeq proteins (4): NP_001317071, NP_001337859, NP_001337860, NP_653262 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR043246 | SPMIP5 | Family |
| IPR055215 | SPMIP5_dom | Domain |
Pfam: PF22573
UniProt features (5 total): splice variant 3, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WW14-F1 | 63.17 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 44 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, NKX25_02, PATIL_LIVER_CANCER, ATF1_Q6, NF1_Q6_01, AFP1_Q6, TGGNNNNNNKCCAR_UNKNOWN, chr10q25, HEB_Q6, FIGUEROA_AML_METHYLATION_CLUSTER_5_DN, FIGUEROA_AML_METHYLATION_CLUSTER_6_DN, FIGUEROA_AML_METHYLATION_CLUSTER_7_DN, IRF1_01, ESC_J1_UP_EARLY.V1_UP, CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (6): nucleus (GO:0005634), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
292 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPMIP5 | TMEM234 | Q8WY98 | 418 |
| SPMIP5 | RPP21 | Q9H633 | 397 |
| SPMIP5 | TCEAL8 | Q8IYN2 | 371 |
| SPMIP5 | RNF17 | Q9BXT8 | 367 |
| SPMIP5 | MAGEB6 | Q8N7X4 | 359 |
| SPMIP5 | UBE2U | Q5VVX9 | 350 |
| SPMIP5 | SPATA22 | Q8NHS9 | 343 |
| SPMIP5 | FOXR1 | Q6PIV2 | 342 |
| SPMIP5 | ASIC5 | Q9NY37 | 341 |
| SPMIP5 | LRRC52 | Q8N7C0 | 337 |
| SPMIP5 | AVL9 | Q8NBF6 | 337 |
| SPMIP5 | FABP12 | A6NFH5 | 331 |
| SPMIP5 | ZFYVE28 | Q9HCC9 | 325 |
| SPMIP5 | VWA7 | Q9Y334 | 322 |
| SPMIP5 | EQTN | Q9NQ60 | 321 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RIMOC1 | SPMIP5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TEX11 | SPMIP5 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SPMIP5 | WDHD1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): C10orf82 (Two-hybrid), C10orf82 (Two-hybrid), C10orf82 (Two-hybrid), C10orf82 (Two-hybrid), C10orf82 (Two-hybrid), ANKRD11 (Two-hybrid), MKRN3 (Two-hybrid), GPSM3 (Two-hybrid), WDHD1 (Affinity Capture-MS), JMJD4 (Affinity Capture-MS), CCDC51 (Affinity Capture-MS), TDP2 (Affinity Capture-MS), KIF3A (Affinity Capture-MS), C10orf82 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WRI3, A2BFC9, A2RRW4, A4QMS7, A6NJV1, A6NL82, A6QPC0, A6QQ68, A8E4X8, A8E5W8, A8QW39, A9JS51, D6REC4, F1P3Y5, G3X6E2, P0C875, Q0VB26, Q1MSJ5, Q2IA00, Q2T9Q3, Q2TA11, Q3UY96, Q494V2, Q497Q6, Q4KKZ1, Q4QR77, Q4R5Y0, Q4R8V8, Q5NC57, Q5ZIH9, Q6J272, Q6PII3, Q6ZQR2, Q6ZVS7, Q7Z4T9, Q8CFW7, Q8N1D5, Q8N6G2, Q8WW14, Q95LR0
Diamond homologs: A6QPC0, Q8WW14, Q9CQT6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
850 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:116664170:TCAC:T | donor_loss | 1.0000 |
| 10:116664171:CACCT:C | donor_loss | 1.0000 |
| 10:116664172:ACCTG:A | donor_loss | 1.0000 |
| 10:116664173:CCTG:C | donor_loss | 1.0000 |
| 10:116664267:ATATT:A | acceptor_gain | 1.0000 |
| 10:116664268:TATT:T | acceptor_gain | 1.0000 |
| 10:116664269:ATT:A | acceptor_gain | 1.0000 |
| 10:116664270:TT:T | acceptor_gain | 1.0000 |
| 10:116664271:TCTA:T | acceptor_loss | 1.0000 |
| 10:116664272:C:CC | acceptor_gain | 1.0000 |
| 10:116664278:C:CT | acceptor_gain | 1.0000 |
| 10:116664279:A:T | acceptor_gain | 1.0000 |
| 10:116664755:ACT:A | donor_loss | 1.0000 |
| 10:116664756:CTC:C | donor_loss | 1.0000 |
| 10:116664757:TCA:T | donor_loss | 1.0000 |
| 10:116664759:A:AC | donor_gain | 1.0000 |
| 10:116664759:A:C | donor_loss | 1.0000 |
| 10:116664759:ACT:A | donor_gain | 1.0000 |
| 10:116664760:C:CG | donor_gain | 1.0000 |
| 10:116664760:CT:C | donor_gain | 1.0000 |
| 10:116664760:CTC:C | donor_gain | 1.0000 |
| 10:116664760:CTCT:C | donor_gain | 1.0000 |
| 10:116664760:CTCTT:C | donor_gain | 1.0000 |
| 10:116665607:C:A | donor_gain | 1.0000 |
| 10:116665626:A:AC | donor_gain | 1.0000 |
| 10:116665627:C:CC | donor_gain | 1.0000 |
| 10:116665629:G:GA | donor_gain | 1.0000 |
| 10:116665638:A:AC | donor_gain | 1.0000 |
| 10:116665639:C:CC | donor_gain | 1.0000 |
| 10:116665664:T:TA | donor_gain | 1.0000 |
AlphaMissense
1522 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:116664900:A:G | W108R | 0.988 |
| 10:116664900:A:T | W108R | 0.988 |
| 10:116665822:A:C | F20L | 0.981 |
| 10:116665822:A:T | F20L | 0.981 |
| 10:116665824:A:G | F20L | 0.981 |
| 10:116664898:C:A | W108C | 0.977 |
| 10:116664898:C:G | W108C | 0.977 |
| 10:116664811:G:C | F137L | 0.972 |
| 10:116664811:G:T | F137L | 0.972 |
| 10:116664813:A:G | F137L | 0.972 |
| 10:116664823:G:C | C133W | 0.970 |
| 10:116664825:A:G | C133R | 0.969 |
| 10:116668292:G:C | F7L | 0.964 |
| 10:116668292:G:T | F7L | 0.964 |
| 10:116668294:A:G | F7L | 0.964 |
| 10:116664880:T:A | R114S | 0.960 |
| 10:116664880:T:G | R114S | 0.960 |
| 10:116665756:G:C | F42L | 0.955 |
| 10:116665756:G:T | F42L | 0.955 |
| 10:116665758:A:G | F42L | 0.955 |
| 10:116668286:T:A | R9S | 0.952 |
| 10:116668286:T:G | R9S | 0.952 |
| 10:116664899:C:G | W108S | 0.949 |
| 10:116664834:C:G | A130P | 0.948 |
| 10:116664884:G:T | P113Q | 0.945 |
| 10:116664869:G:A | T118I | 0.943 |
| 10:116664887:A:G | L112P | 0.943 |
| 10:116668258:C:G | G19R | 0.943 |
| 10:116664902:C:T | G107D | 0.939 |
| 10:116665646:A:G | L79P | 0.939 |
dbSNP variants (sampled 300 via entrez): RS1000145952 (10:116662262 G>C), RS1000990091 (10:116668106 C>A,T), RS1002321136 (10:116662761 A>C), RS1002344527 (10:116669216 A>T), RS1002374092 (10:116668914 C>A,G), RS1002643896 (10:116670603 A>G), RS1002711037 (10:116670287 G>A,C), RS1002784850 (10:116670135 G>A), RS1004045241 (10:116664702 T>C), RS1005349879 (10:116670720 C>T), RS1005687284 (10:116666248 C>T), RS1005718446 (10:116665956 T>C), RS1006030887 (10:116667599 C>A,T), RS1006060425 (10:116667336 G>A), RS1006581436 (10:116666641 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_66 | Body mass index | 4.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Vorinostat | affects cotreatment, decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Lead | affects expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.